Olanzapine: Difference between revisions
| Line 1: | Line 1: | ||
==Administration== | ==Administration== | ||
*Type: [[Antipsychotic]], second generation | *Type: [[Antipsychotic]], second generation | ||
*Dosage Forms: | *Dosage Forms: tablets, solution, suspension | ||
*Routes of Administration: | *Routes of Administration: oral, intramuscular | ||
*Common Trade Names: Zyprexa, Zydis | *Common Trade Names: Zyprexa, Zydis | ||
Revision as of 16:17, 10 August 2016
Administration
- Type: Antipsychotic, second generation
- Dosage Forms: tablets, solution, suspension
- Routes of Administration: oral, intramuscular
- Common Trade Names: Zyprexa, Zydis
Adult Dosing
- Acute agitation (associated with schizophrenia or bipolar disorder): short-sting IM injection: initial dose 10 mg IM (consider lowering to 5 or 7.5 mg depending on clinical factors), additional dose 10 mg IM maybe considered. Allowed 2 hours after the first dose and 4 hours after the second dose to evaluate response (Maximum dose 30 mg/day)
- Special risk patients: consider lowering dose to 2.5 mg in patients who are debilitated, who have risk of hypotension or who maybe more pharmacodynamically sensitive to olanzapine.
- Schizophrenia
Pediatric Dosing
Special Populations
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: